Diagnosis of in utero Parvovirus B19 infection and maternal immune response – the relevance of linear epitopes and advanced serologic testing

Bibliography

• Brown T, Anand A, Ritchie LD, Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984;2(8410):1033-4
   PubMed Web of Science ®Google Scholar
• Deiss V, Tratschin JD, Weitz M, Siegl G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 1990;175(1):247-54
   PubMed Web of Science ®Google Scholar
• Blundell MC, Beard C, Astell CR. In vitro identification of a B19 parvovirus promoter. Virology 1987;157(2):534-8
   PubMed Web of Science ®Google Scholar
• Shade RO, Blundell MC, Cotmore SF, Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58(3):921-36
   PubMed Web of Science ®Google Scholar
• Anderson S, Momoeda M, Kawase M, Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 1995;206(1):626-32
   PubMed Web of Science ®Google Scholar
• Kawase M, Momoeda M, Young NS, Kajigaya S. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 1995;211(2):359-66
   PubMed Web of Science ®Google Scholar
• Modrow S, Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 2002;50(5):326-31
   PubMed Web of Science ®Google Scholar
• Dorsch S, Liebisch G, Kaufmann B, The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 2002;76(4):2014-8
   PubMed Web of Science ®Google Scholar
• Zádori Z, Szelei J, Lacoste MC, A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 2001;1(2):291-302
   PubMed Web of Science ®Google Scholar
• Moffatt S, Yaegashi N, Tada K, Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998;72(4):3018-28
   PubMed Web of Science ®Google Scholar
• Servant A, Laperche S, Lallemand F, Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002;76(18):9124-34
   PubMed Web of Science ®Google Scholar
• Ekman A, Hokynar K, Kakkola L, Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol 2007;81(13):6927-35
   PubMed Web of Science ®Google Scholar
• Norja P, Hokynar K, Aaltonen LM, Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 2006;103(19):7450-3
   PubMed Web of Science ®Google Scholar
• Schneider B, Höne A, Tolba RH, Simultaneous persistence of multiple genome variants of human parvovirus B19. J Gen Virol 2008;89(Pt 1):164-76
   PubMedGoogle Scholar
• Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262(5130):114-7
   PubMed Web of Science ®Google Scholar
• Brown KE, Hibbs JR, Gallinella G, Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330(17):1192-6
   PubMed Web of Science ®Google Scholar
• Chisaka H, Morita E, Yaegashi N, Sugamura K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol 2003;13(6):347-59
   PubMed Web of Science ®Google Scholar
• Saal JG, Steidle M, Einsele H, Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992;12(4):147-51
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Murai C, Shibata S, Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95(14):8227-32
   PubMed Web of Science ®Google Scholar
• Munakata Y, Kato I, Saito T, Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement. Virology 2006;345(1):251-7
   PubMed Web of Science ®Google Scholar
• Söderlund-Venermo M, Hokynar K, Nieminen J, Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 2002;50(5):307-16
   PubMed Web of Science ®Google Scholar
• Bültmann BD, Klingel K, Sotlar K, Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003;34(1):92-5
   PubMed Web of Science ®Google Scholar
• Bültmann BD, Klingel K, Sotlar K, Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch 2003;442(1):8-17
   PubMed Web of Science ®Google Scholar
• Pankuweit S, Moll R, Baandrup U, Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 2003;34(5):497-503
   PubMed Web of Science ®Google Scholar
• Bousvaros A, Sundel R, Thorne GM, Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol 1998;26(5):365-9
   PubMed Web of Science ®Google Scholar
• Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001;5(5):320-30
   PubMed Web of Science ®Google Scholar
• Brown KE, Green SW, Antunez de Mayolo J, Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994;343(8902):895-6
   PubMed Web of Science ®Google Scholar
• Weiland HT, Vermey-Keers C, Salimans MM, Parvovirus B19 associated with fetal abnormality. Lancet 1987;1(8534):682-3
   PubMed Web of Science ®Google Scholar
• Tiessen RG, van Elsacker-Niele AM, Vermeij-Keers C, A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn 1994;14(3):173-6
   PubMed Web of Science ®Google Scholar
• Konstantinidou AE, Syridou G, Spanakis N, Association of hypospadias and cardiac defect in a parvovirus B19-infected stillborn: a causality relation? J Infect 2007;54(1):e41-5
   PubMedGoogle Scholar
• Busby A, Dolk H, Armstrong B. Eye anomalies: seasonal variation and maternal viral infections. Epidemiology 2005;16(3):317-22
   PubMed Web of Science ®Google Scholar
• Glenn OA, Bianco K, Barkovich AJ, Fetal cerebellar hemorrhage in parvovirus-associated non-immune hydrops fetalis. J Matern Fetal Neonatal Med 2007;20(10):769-72
   PubMed Web of Science ®Google Scholar
• Van Elsacker-Niele AM, Salimans MM, Weiland HT, Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol 1989;96(7):768-75
   PubMedGoogle Scholar
• Lunardi C, Tinazzi E, Bason C, Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 2008;8(2):116-20
   PubMed Web of Science ®Google Scholar
• Di Domenico C, Moschese V, Chini L, Perinatal infections of B19 parvoviruses. Ig Sanita Pubbl 2002;58(3):155-62
   Google Scholar
• de Freitas RB, Wong D, Boswell F, Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil. J Med Virol 1990;32(4):203-8
   PubMed Web of Science ®Google Scholar
• Enders M, Weidner A, Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 2007;135(4):563-9
   PubMed Web of Science ®Google Scholar
• Da Silva AR, Nogueira SA, Alzeguir JC, Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro. Rev Soc Bras Med Trop 2006;39(5):467-72
   PubMed Web of Science ®Google Scholar
• Van Gessel PH, Gaytant MA, Vossen AC, Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: a prospective study. Eur J Obstet Gynecol Reprod Biol 2006;128(1-2):46-9
   PubMed Web of Science ®Google Scholar
• Rathore MH. Parvovirus B19. In: Hutto C, Scott GB, editors, Congenital and perinatal infections. Humana press, Totowa, NJ, USA; 2006. p. 131
   Google Scholar
• Beigi RH, Wiesenfeld HC, Landers DV, Simhan HN. High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy. Infect Dis Obstet Gynecol 2008;2008:524601
   PubMedGoogle Scholar
• Gratacós E, Torres PJ, Vidal J, The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995;171(5):1360-3
   PubMed Web of Science ®Google Scholar
• Yaegashi N, Niinuma T, Chisaka H, The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 1998;37(1):28-35
   PubMed Web of Science ®Google Scholar
• Rodis JF, Borgida AF, Wilson M, Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 1998;179(4):985-8
   PubMed Web of Science ®Google Scholar
• Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105(2):174-8
   PubMedGoogle Scholar
• Prospective study of human parvovirus (B19) infection in pregnancy. Public health laboratory service working party on fifth disease. BMJ 1990;300(6733):1166-70
   Google Scholar
• Enders M, Weidner A, Zoellner I, Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24(7):513-8
   PubMed Web of Science ®Google Scholar
• Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 2002;21(12):1133-6
   PubMed Web of Science ®Google Scholar
• Mark Y, Rogers BB, Oyer CE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II. DNA amplification. Pediatr Pathol 1993;13(3):381-6
   PubMedGoogle Scholar
• Rogers BB, Mark Y, Oyer CE. Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology. Pediatr Pathol 1993;13(3):371-9
   PubMedGoogle Scholar
• Rodis JF, Hovick TJ Jr, Quinn DL, Human parvovirus infection in pregnancy. Obstet Gynecol 1988;72(5):733-8
   PubMed Web of Science ®Google Scholar
• Yaegashi N, Okamura K, Yajima A, The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. J Perinat Med 1994;22(2):159-63
   PubMed Web of Science ®Google Scholar
• Jordan JA. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996;174(1 Pt 1):37-42
   PubMed Web of Science ®Google Scholar
• Essary LR, Vnencak-Jones CL, Manning SS, Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods. Hum Pathol 1998;29(7):696-701
   PubMed Web of Science ®Google Scholar
• Gilbert GL. Parvovirus B19 infection and its significance in pregnancy. Commun Dis Intell 2000;24(Suppl):69-71
   PubMedGoogle Scholar
• Skjöldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG 2000;107(4):476-80
   PubMed Web of Science ®Google Scholar
• Tolfvenstam T, Papadogiannakis N, Norbeck O, Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001;357(9267):1494-7
   PubMed Web of Science ®Google Scholar
• Petersson K, Norbeck O, Westgren M, Broliden K. Detection of parvovirus B19, cytomegalovirus and enterovirus infections in cases of intrauterine fetal death. J Perinat Med 2004;32(6):516-21
   PubMed Web of Science ®Google Scholar
• Riipinen A, Väisänen E, Nuutila M, Parvovirus b19 infection in fetal deaths. Clin Infect Dis 2008;47(12):1519-25
   PubMed Web of Science ®Google Scholar
• Jordan JA, Butchko AR. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody. Placenta 2002;23(7):547-53
   PubMed Web of Science ®Google Scholar
• Török TJ. Human parvovirus B19 infections in pregnancy. Pediatr Infect Dis J 1990;9(10):772-6
   PubMed Web of Science ®Google Scholar
• Wattre P, Dewilde A, Subtil D, A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection. J Med Virol 1998;54(2):140-4
   PubMed Web of Science ®Google Scholar
• Ergaz Z, Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol 2006;21(4):421-35
   PubMed Web of Science ®Google Scholar
• Enders G, Dötsch J, Bauer J, Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis 1998;26(2):355-8
   PubMed Web of Science ®Google Scholar
• Morel O, Chagnaud S, Laperrelle J, Parvovirus B19 in pregnancy: literature review. Gynecol Obstet Fertil 2007;35(11):1095-104
   PubMed Web of Science ®Google Scholar
• Kempe A, Rösing B, Berg C, First-trimester treatment of fetal anemia secondary to parvovirus B19 infection. Ultrasound Obstet Gynecol 2007;29(2):226-8
   PubMed Web of Science ®Google Scholar
• Cosmi E, Mari G, Delle Chiaie L, Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002;187(5):1290-3
   PubMed Web of Science ®Google Scholar
• Moise KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol 2008;198(2):161. e1-4
   PubMedGoogle Scholar
• Brochot C, Debever P, Subtil D, Puech F. Which supervision and treatment to use in case of exposure to Parvovirus B19 during pregnancy? Gynecol Obstet Fertil 2008;36(2):204-11
   PubMed Web of Science ®Google Scholar
• Pryde PG, Nugent CE, Pridjian G, Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol 1992;79(5 Pt 2):859-61
   PubMed Web of Science ®Google Scholar
• Sheikh AU, Ernest JM, O'Shea M. Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 1992;167(2):337-41
   PubMed Web of Science ®Google Scholar
• Dembinski J, Eis-Hübinger AM, Maar J, Long term follow up of serostatus after maternofetal parvovirus B19 infection. Arch Dis Child 2003;88(3):219-21
   PubMed Web of Science ®Google Scholar
• Nagel HT, de Haan TR, Vandenbussche FP, Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007;109(1):42-7
   PubMed Web of Science ®Google Scholar
• Pistorius LR, Smal J, de Haan TR, Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther 2008;24(4):491-4
   PubMed Web of Science ®Google Scholar
• Manaresi E, Zuffi E, Gallinella G, Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins. J Med Virol 2001;64(1):67-73
   PubMed Web of Science ®Google Scholar
• Peterlana D, Puccetti A, Corrocher R, Lunardi C. Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta 2006;372(1-2):14-23
   PubMed Web of Science ®Google Scholar
• Searle K, Guilliard C, Wallat S, Acute parvovirus B19 infection in pregnant women–an analysis of serial samples by serological and semi-quantitative PCR techniques. Infection 1998;26(3):139-43
   PubMed Web of Science ®Google Scholar
• Pfrepper KI, Enders M, Motz M. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J Vet Med B Infect Dis Vet Public Health 2005;52(7-8):362-5
   PubMedGoogle Scholar
• Söderlund M, Brown CS, Spaan WJ, Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 1995;172(6):1431-6
   PubMed Web of Science ®Google Scholar
• Searle K, Schalasta G, Enders G. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful. J Med Virol 1998;56(3):192-8
   PubMed Web of Science ®Google Scholar
• Hemauer A, Gigler A, Searle K, Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. J Med Virol 2000;60(1):48-55
   PubMed Web of Science ®Google Scholar
• Dembinski J, Haverkamp F, Maara H, Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002;109(11):1232-4
   PubMed Web of Science ®Google Scholar
• Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006;260(4):285-304
   PubMed Web of Science ®Google Scholar
• Franssila R, Hokynar K, Hedman K. T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19. J Infect Dis 2001;183(5):805-9
   PubMed Web of Science ®Google Scholar
• von Poblotzki A, Gerdes C, Reischl U, Lymphoproliferative responses after infection with human parvovirus B19. J Virol 1996;70(10):7327-30
   PubMed Web of Science ®Google Scholar
• Franssila R, Hedman K. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. Vaccine 2004;22(27-28):3809-15
   PubMed Web of Science ®Google Scholar
• Isa A, Norbeck O, Hirbod T, Aberrant cellular immune responses in humans infected persistently with parvovirus B19. J Med Virol 2006;78(1):129-33
   PubMed Web of Science ®Google Scholar
• Isa A, Kasprowicz V, Norbeck O, Prolonged activation of virus-specific CD8+ T cells after acute B19 infection. PLoS Med 2005;2(12):e343
   PubMedGoogle Scholar
• Klenerman P, Tolfvenstam T, Price DA, T lymphocyte responses against human parvovirus B19: small virus, big response. Pathol Biol (Paris) 2002;50(5):317-25
   PubMed Web of Science ®Google Scholar
• Lindner J, Barabas S, Saar K, CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection. J Vet Med B Infect Dis Vet Public Health 2005;52(7-8):356-61
   PubMedGoogle Scholar
• Zhou S, Ou R, Huang L, Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. J Virol 2004;78(7):3578-600
   PubMed Web of Science ®Google Scholar
• Probst HC, Tschannen K, Gallimore A, Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J Immunol 2003;171(10):5415-22
   PubMed Web of Science ®Google Scholar
• Tzang BS, Chiu CC, Tsai CC, Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J Biomed Sci 2009;16:13
   PubMed Web of Science ®Google Scholar
• Bönsch C, Kempf C, Ros C. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J Virol 2008;82(23):11784-91
   PubMed Web of Science ®Google Scholar
• de Haan TR, Beersma MF, Claas EC, Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses. Fetal Diagn Ther 2007;22(1):55-62
   PubMed Web of Science ®Google Scholar
• Enders M, Helbig S, Hunjet A, Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection. J Virol Methods 2007;146(1-2):409-13
   PubMed Web of Science ®Google Scholar
• Enders M, Schalasta G, Baisch C, Human parvovirus B19 infection during pregnancy–value of modern molecular and serological diagnostics. J Clin Virol 2006;35(4):400-6
   PubMed Web of Science ®Google Scholar
• Jordan JA. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J Clin Microbiol 2000;38(4):1472-5
   PubMed Web of Science ®Google Scholar
• Jordan JA. Diagnosing human parvovirus B19 infection: guidelines for test selection. Mol Diagn 2001;6(4):307-12
   PubMedGoogle Scholar
• Kajigaya S, Fujii H, Field A, Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci USA 1991;88(11):4646-50
   PubMed Web of Science ®Google Scholar
• Kerr S, O'Keeffe G, Kilty C, Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 1999;57(2):179-85
   PubMed Web of Science ®Google Scholar
• Lowin T, Raab U, Schroeder J, Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors. J Vet Med B Infect Dis Vet Public Health 2005;52(7-8):348-52
   PubMedGoogle Scholar
• Ballou WR, Reed JL, Noble W, Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 2003;187(4):675-8
   PubMed Web of Science ®Google Scholar
• Bonvicini F, Manaresi E, Gallinella G, Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. BJOG 2009;116(6):813-7
   PubMed Web of Science ®Google Scholar
• Enders M, Weidner A, Rosenthal T, Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 2008;197(1):58-62
   PubMed Web of Science ®Google Scholar
• Butchko AR, Jordan JA. Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol 2004;42(7):3191-5
   PubMed Web of Science ®Google Scholar
• Manaresi E, Gallinella G, Venturoli S, Detection of parvovirus B19 IgG: choice of antigens and serological tests. J Clin Virol 2004;29(1):51-3
   PubMed Web of Science ®Google Scholar
• Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995;171(3):710-3
   PubMed Web of Science ®Google Scholar
• Kaikkonen L, Lankinen H, Harjunpää I, Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol 1999;37(12):3952-6, Erratum in: J Clin Microbiol 2000;38(2):944
   PubMed Web of Science ®Google Scholar
• Lindblom A, Isa A, Norbeck O, Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 2005;41(8):1201-3
   PubMed Web of Science ®Google Scholar